Research analysts covering Charming Medical.
Recent press releases and 8-K filings for MCTA.
Charming Medical Limited Announces Full Exercise of Over-Allotment Option
MCTA
New Projects/Investments
- Charming Medical Limited announced that Cathay Securities, Inc. fully exercised its over-allotment option.
- This involved the purchase of an additional 240,000 Class A ordinary shares at a public offering price of US$4.00 per share.
- The closing of the sale of these additional shares took place on October 28, 2025.
- The full exercise generated US$960,000 in gross proceeds, bringing the total gross proceeds from the initial public offering to approximately US$7.36 million, before deducting underwriting discounts and other related expenses.
- The company intends to use the net proceeds for expanding its business and geographic coverage, potential strategic investments and acquisitions, research and development, and for general working capital and corporate purposes.
Oct 28, 2025, 9:20 PM
Charming Medical Limited Prices Initial Public Offering
MCTA
Delisting/Listing Issues
New Projects/Investments
M&A
- Charming Medical Limited (Nasdaq: MCTA) announced the pricing of its initial public offering (IPO) of 1,600,000 Class A ordinary shares at $4.00 per share.
- The Class A Ordinary Shares are expected to commence trading on the Nasdaq Capital Market on October 21, 2025, under the ticker symbol "MCTA".
- The Offering is expected to generate gross proceeds of approximately $6.4 million, before deducting underwriting discounts and other expenses. If the over-allotment option for an additional 240,000 Class A Ordinary Shares is exercised in full, the gross proceeds would amount to approximately $7.36 million.
- The company intends to use the net proceeds for expanding its business and geographic coverage, potential strategic investments and acquisitions, research and development, and for general working capital and corporate purposes.
Oct 22, 2025, 8:05 PM
Charming Medical Closes Initial Public Offering
MCTA
Listing Issues
New Projects/Investments
M&A
- Charming Medical Limited (MCTA) announced the closing of its initial public offering (IPO) of 1,600,000 Class A ordinary shares at a price of $4.00 per share.
- The company received gross proceeds of $6.4 million from the offering.
- MCTA's Class A Ordinary Shares began trading on the Nasdaq Capital Market under the symbol "MCTA" on October 21, 2025.
- Net proceeds from the offering are intended for business and geographic expansion, potential strategic investments and acquisitions, research and development, and general working capital.
- An over-allotment option for an additional 240,000 Class A Ordinary Shares was granted, which, if fully exercised, would increase gross proceeds to approximately $7.36 million.
Oct 22, 2025, 4:51 PM
Charming Medical Limited Announces IPO Pricing and Nasdaq Listing
MCTA
Delisting/Listing Issues
New Projects/Investments
- Charming Medical Limited priced its initial public offering (IPO) of 1,600,000 Class A ordinary shares at $4.00 per share.
- The Class A Ordinary Shares are expected to commence trading on the Nasdaq Capital Market on October 21, 2025, under the ticker symbol "MCTA".
- The Offering is anticipated to generate approximately $6.4 million in gross proceeds, potentially increasing to $7.36 million if the underwriters' over-allotment option for an additional 240,000 shares is fully exercised.
- The company, a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, intends to use the net proceeds for business expansion, strategic investments, research and development, and general corporate purposes.
Oct 21, 2025, 3:00 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more